<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2268">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 10, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03324711</url>
  </required_header>
  <id_info>
    <org_study_id>15/B/26</org_study_id>
    <nct_id>NCT03324711</nct_id>
  </id_info>
  <brief_title>Psychometric Validation of the &quot;Antillanisée&quot; Version of the Mini Mental State Examination (MMSEa)</brief_title>
  <acronym>MMENSEA</acronym>
  <official_title>Psychometric Validation of the &quot;Antillanisée&quot; Version of the Mini Mental State Examination</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Center of Martinique</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Center of Martinique</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of the study is to analyze the psychometric properties of the&#xD;
      &quot;antillanisée&quot; version of the Mini Mental State Examination (MMSEa).&#xD;
&#xD;
      The methodology used will permit to explore the feasibility, acceptability, validity and&#xD;
      reliability of the tool.&#xD;
&#xD;
      The psychometric validation of a version adapted transculturally will increase the value of&#xD;
      the results obtained with this test and will make it possible to refine the screening of&#xD;
      existing cognitive disorders for elderly subjects with Alzheiner's disease or related&#xD;
      disorders.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be recruited at the Geriatric Day Hospital.&#xD;
&#xD;
      These patients came to a geriatric day hospital for examination without restriction on the&#xD;
      reason for the hospitalization.&#xD;
&#xD;
      They are referred by their general practitionner or referred by a specialist physician, live&#xD;
      at home or in an institution and are representative of the geriatric population addressed by&#xD;
      the MMSEa.&#xD;
&#xD;
        -  The main objective of the study is to analyze the psychometric properties of the&#xD;
           &quot;antillanisée&quot; version of the Mini Mental State Examination (MMSEa).&#xD;
&#xD;
        -  The ancillary objective of this study will be to carry out the psychometric validation&#xD;
           of the Short Physical Performance Battery (SPPB) in people aged 65 years or older.&#xD;
&#xD;
      It is an instrument for measuring the physical performance of subjects whose transcultural&#xD;
      adaptation and psychometric validation have already been performed in subjects aged 65 to 74&#xD;
      years.&#xD;
&#xD;
      SPPB is used routinely in our routine practice in a day hospital, with no psychometric&#xD;
      validation performed on this population. This ancillary objective will not modify the course&#xD;
      of the MMSEa validation study since the SPPB is part of the evaluation tools.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Departure of the Principal Investigator&#xD;
  </why_stopped>
  <start_date type="Actual">November 15, 2016</start_date>
  <completion_date type="Actual">July 2019</completion_date>
  <primary_completion_date type="Actual">April 11, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of the psychometric properties of the questionnaire MMSEa</measure>
    <time_frame>12 month (+/- 15 days)</time_frame>
    <description>The following will be measured:&#xD;
feasibility and acceptability;&#xD;
validity of structure;&#xD;
discriminant validity;&#xD;
predictive validity;&#xD;
validity of convergence;&#xD;
reliability (internal consistency,reproducibility (test-retest)).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the psychometric properties of questionnaire SPPB</measure>
    <time_frame>12 month (+/- 15 days)</time_frame>
    <description>The following will be measured:&#xD;
feasibility and acceptability;&#xD;
validity of structure;&#xD;
discriminant validity;&#xD;
predictive validity;&#xD;
reliability (internal consistency,reproducibility (test-retest)).</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Elderly Patients</condition>
  <condition>Cognitive Disorder</condition>
  <condition>Alzheimer Disease</condition>
  <arm_group>
    <arm_group_label>Elderly patient (65 and more)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Ederly patients seen in geriatric day hospital, from creole culture.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>&quot;Antillanisée&quot; Mini Mental State Examination (MMSEa)</intervention_name>
    <description>&quot;Antillanisée&quot; version of the Mini Mental State Examination (MMSEa), is a version adaptated to the French West Indies creole culture.</description>
    <arm_group_label>Elderly patient (65 and more)</arm_group_label>
    <other_name>MMSEa</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject of 65 years old and over&#xD;
&#xD;
          -  Subject admitted in a geriatric day hospital&#xD;
&#xD;
          -  Patients of creole culture&#xD;
&#xD;
          -  Subject having French and/or Creole as mother tongue&#xD;
&#xD;
          -  Subject able to undergo neuropsychological tests&#xD;
&#xD;
          -  Subject having given informed consent or, informed consent given by his or her primary&#xD;
             caregiver&#xD;
&#xD;
          -  Subject affiliated to a social security scheme&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject with a disability seriously compromising oral communication (understanding and&#xD;
             expression)&#xD;
&#xD;
          -  Subject with behavioral disorder that does not allow for testing&#xD;
&#xD;
          -  Subject in general condition not allowing its participation in the tests&#xD;
&#xD;
          -  Subject involved in another study including an exclusion period still in progress at&#xD;
             the time of inclusion&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lidvine GODAERT-SIMON, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU of Martinique</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU de Martinique</name>
      <address>
        <city>Fort-de-France</city>
        <state>Martinique</state>
        <zip>97200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2022</verification_date>
  <study_first_submitted>January 11, 2017</study_first_submitted>
  <study_first_submitted_qc>October 24, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 30, 2017</study_first_posted>
  <last_update_submitted>February 22, 2022</last_update_submitted>
  <last_update_submitted_qc>February 22, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cognitive disorders</keyword>
  <keyword>Alzheimer's disease</keyword>
  <keyword>Mini Mental State Examination</keyword>
  <keyword>Geriatry</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
    <mesh_term>Cognition Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

